Special Reminder:
Penicillin products such as amoxicillin have fluctuated and adjusted, tetracycline products such as doxycycline hydrochloride have risen, chloramphenicol products have fallen, and antipyretic and analgesic products have strengthened.
Penicillin products are mainly stable.
Amoxicillin, in the first week of the second half of the year, there were changes in international trade demand, high domestic market heat, active trading, and fluctuating market adjustments.
Amoxicillin sodium has a stable market price of around 290, with a slight downward trend in July.
Amoxicillin and clavulanic acid potassium have high popularity and active trading. The market has slightly increased compared to last week, with a year-on-year decrease of more than 30%. The average prices for the second quarter of last year from April to June were 776, 740, and 694, respectively. The average prices for the second quarter from April to June were 800, 830, and 810, respectively.
Ampicillin, Ampicillin Sodium. Ampicillin, running smoothly, with a market price of around 180; Ampicillin sodium has not changed much in the market compared to last week, with a price drop of over 100 yuan per kilogram compared to the same period last year.
Penicillin sodium has remained stable compared to last week, with prices ranging from 150 in the same period of 2025 to 225 in the same period of 2024, with a decline of over 20%. The market trend remained stable in July.
Penicillin potassium industrial salt experienced a volatile adjustment in the market, with a slight rebound compared to last week. The trading range for the second quarter of this year was between 59-69, with a smaller amplitude than last year. The downward trend of the market slowed down in May last year, falling below the 100 line at the end of June and below the 90 line in July. The average prices for July in the past five years from 2025 to 2021 are 85, 141, 150, 142, and 98, respectively.
Cefotaxime Sodium and Cefotaxime Hydrochloride have a stable market, with significant differences in transaction prices depending on the brand and region. Cefotaxime sodium has not changed much compared to last week's market, with a year-on-year decrease of over 10%; Cefotaxime hydrochloride has a market price of around 780 yuan, with average prices of 1048 yuan, 995 yuan, and 1290 yuan from June 2025 to June 2023, respectively.
Cefotaxime sulfate, operating weakly, market price 3690, with a month on month decrease of 0.5% and a year-on-year decrease of 19.6%. The average prices for July in the past three years from 2025 to 2023 are as follows:
4462, 5296, 5895.
The Asia Pacific Yihe Data Analysis Research Institute focuses on products.
Penicillin products showed an overall downward trend in the first half of the year, with a significant decrease compared to the first half of last year. In the first quarter, amoxicillin experienced a fluctuating adjustment with a downward trend. It rose to 170 in January, fell back in early February, rose again to the 180 line at the end of February and early March, and fell again to the 170 line at the end of the quarter; Spiral decline from April to June; Penicillin potassium industrial salt broke through the 80 line at the end of January in the first quarter, gradually fell below 70 again at the end of February during the Spring Festival, approached the 60 line at the end of March, fell below 60 again in May, and fluctuated around 60 in June.
Cefotaxime products showed a stable and slightly declining trend in the first half of the year, with a slight rebound in the first and second weeks of March. The trading market price of Cefotaxime Sodium remained stable in the range of 780-860, while Cefotaxime Sulfate was around 3800. In the second quarter, the decline was significant after mid May, with some brands experiencing a decline of more than 5%. The transaction price range of Cefotaxime Hydrochloride in the second quarter was between 700-760.
Original article by Asia Pacific Yihe Data Analysis Research Institute. Reproduction without permission is prohibited and infringement will be investigated. Please contact the author for reproduction and citation, and indicate the original source.
Chloramphenicol products have steadily declined, while tetracycline products have risen in price.
Fluphenicol has significant differences in transaction prices among different regions and brands, with market prices below the 170 line and transaction prices in some regions below the 160 line. The average prices for the third quarter of 2025 from July to September are as follows:
166, 165, 166; The average prices for the third quarter of 2024 from July to September are as follows:
191, 189, 188.
The Asia Pacific Yihe Data Analysis Research Institute focuses on products.
Thiamphenicol has a stable market price of around 170, with a month on month increase of 0.4% and a year-on-year decrease of 10.5%.
Hydrochloric acid doxycycline has risen in price compared to last week, with high popularity, active trading, and an increase in trading market brands.
Oxytetracycline and oxytetracycline hydrochloride. Oxytetracycline, with little change in market trend compared to last week; Oxytetracycline hydrochloride has a stable market with a trading range of 96-100, and its trading price has remained basically unchanged in the same period of the past three years.
Chlortetracycline hydrochloride is on the rise, with a market trading price of around 160.
The overall market for aminoglycoside products is stable.
Neomycin sulfate has a market price of 142-155 billion yuan. The average prices for the same period in the past five years from 2025 to 2021 were 159, 148, 127, 149, and 143, respectively. The market remained stable in June.
Hydrochloric acid (sulfuric acid) spectinomycin has high popularity and active trading, with a slight increase in transaction prices compared to last week. The average prices from 2025 to June 2023 were 568, 505, and 500, respectively, and the market trend remained stable in June.
Related information: In June, Shandong LuKang Pharmaceutical Co., Ltd. passed the GMP inspection for non sterile raw materials D-grade chloramphenicol hydrochloride and chloramphenicol sulfate.
Streptomycin sulfate has remained stable compared to last week.
Amphotericin sulfate, with a market price of 190, remained stable at around 190 in the second quarter, with relatively small fluctuations. The average prices for the second quarter of 2025 and 2024 are 203 and 215 respectively.
Kanamycin monosulfate has a stable market trend, with an average trading price of 286 in the second quarter, a decrease of over three percentage points compared to the second quarter of last year.
Amikacin sulfate, market price 725, stable trend in June.
Gentamicin sulfate has a stable market with little change compared to last week.
Aminoglycoside products, with small fluctuations in the market in the first half of the year and mainly stable market conditions. The first quarter of neomycin sulfate showed a trend of "stable start - narrow stability - slight decline", with prices mainly fluctuating within the narrow range of 153-155/billion in January and February. In March, the price range shifted downwards to 145-155/billion, with a year-on-year decline expanding from 3% to 6%. The overall market is in the stage of destocking, and downward pressure continues to exist, but the fluctuation amplitude during the quarter is not significant. In mid to late March, the heat increased and trading activity increased; There was a slight rebound in early May of the second quarter, and the market gradually declined in June. The transaction price range of chloramphenicol hydrochloride in the first quarter was 535-555, with an increase of over 3%; The market remained stable at around 540 in the second quarter. The price range of streptomycin sulfate in the first half of the year is 262-310; The average prices of ampicillin sulfate in the first and second quarters were 191 and 187, respectively. The average prices of kanamycin sulfate in the first and second quarters were 294 and 286, respectively. The market for gentamicin sulfate rose in the first quarter and rebounded at the end of May in the second quarter.
The market for macrolide products has fluctuated and adjusted.
Tartrate Tylosin, with a market price of 252, 2025-2023. The average prices in July of the past three years are as follows:
281, 214, 252.
Tilmicosin and Tilmicosin phosphate. After the CPHI China conference, there was a surge in bulk trading orders in the international market, and the trading market was active. The average prices for the second quarter of last year from April to June were 360, 380, and 370, respectively.
Tartrate Guitarimycin, weakly running, market price 365.
Tartrate tetracycline, with a market price of around 380, has decreased compared to last week, with a year-on-year decline of 4.4% and a decline of 2.5% in the second quarter. Compared to the same period in 2024 and 2023, it decreased by 1.8% and 26.2% respectively.
Teramycin has a stable market price of 5800 yuan.
Erythromycin thiocyanate has a market price of around 485, which is basically the same as the same period last year in the range of 466-505. The average prices from July to September in the third quarter of last year were
494, 489, 498,
Compared to the same period in 2024 and 2023, the increase has exceeded five percentage points.
Sulfuric acid colistin has remained stable compared to last week.
The market price of Corydalis yanhusuo acid tetracycline is 255, which is basically the same as last week's price, with a year-on-year increase of 4.9%.
Lincomycin hydrochloride has a stable market with little change compared to last week. The market price range is 310-329, lower than last year's 409-438 price range, and the price range for the same period in 2023 is 298-320.
Related information: Henan Renhua Biotechnology Co., Ltd. has obtained approval number for lincomycin hydrochloride, with the original veterinary drug number 163561361. Approval date: March 20, 2026, expiration date: March 19, 2031.
For more information, please join the Asia Pacific Yihe Data Analysis Research Institute as a member to stay up-to-date with market changes.
The overall market for quinolone products is stable, with narrow fluctuations in the second quarter being the main trend.
Enrofloxacin, Enrofloxacin Hydrochloride. The market price is 169, with a stable range of around 160 in June and a stable trend in July.
Lactic acid (hydrochloric acid) ciprofloxacin, price 160, overall stable market, stable compared to last week, with a year-on-year decrease of 10.2%. The average prices from 2025 to July 2023 are
180, 189, 206.
Salafloxacin hydrochloride, market price 400.
Mabofloxacin, stable trend, market price 2360, a significant decrease compared to the same period last year.
The overall market for sulfonamide products is mainly stable.
Sulfonamide methoxypyrimidine (sodium), operating strongly, has a market price of 215-245, with a month on month increase of 0.6% and a year-on-year increase of 6.5%, higher than the 185-235 range in the same period of 2025 and basically unchanged from the price range in the same period of 2023.
Sulfonamide trimethoprim (sodium) has a stable market price of 240-255.
Sulfamethoxazole (sodium) has a stable market.
Sulfonamide pyrimidine (sodium) has a stable market price of 159-169. From April to June in the second quarter of 2025, the market transaction prices were 165, 166, and 159, respectively.
Sulfamethoxazine (sodium), with a market price of around 120, is expected to remain stable in July.
Sodium sulfaquinoxaline has not changed much in the market compared to last week.
Sodium sulfamethoxazole remained relatively stable in price compared to last week, with a narrow range of fluctuations in the second quarter and an average price of 209. The market trend remained stable in July.
Sodium sulfamethoxazole has a market price of 189, with little change compared to last week. The average prices for the first half of 2025 from January to June are 175, 176, 173, 171, 169, and 167, respectively.
Dimethyl trimethoprim, operating strongly, with a market price of 400.
Trimethoprim, Trimethoprim lactate. Methoxybenzylidene, with stable market conditions and eased supply; Lactic acid trimethoprim has a market price of around 190, which is stable compared to the same period in 2025 and 2021, and nearly three percentage points higher than the same period in 2024, 2023, and 2022. The average prices for the same period in the past five years from 2025 to 2021 were 190, 182, 188, 188, and 195, respectively. The market trend in June was weak.
Anti parasitic products operate smoothly overall.
Albendazole, with a market price of 129-149, has experienced fluctuations and adjustments in the market, with a year-on-year decrease of nearly 10%. There are significant differences in transaction prices among different regions and brands, and domestic market demand is stabilizing. International trade transactions are active.
Fenbendazole has a stable market price of 238, with little change in price compared to last week and a year-on-year increase of 3.7%.
Abamectin is mainly stable in the market.
Ivermectin has a stable market price of 770, which is basically the same as the transaction price in the same period last year, with a decrease of 8.4% and 29.0% compared to the same period in 2024 and 2023, respectively.
Dikezhuli, with a market price of 920, remained relatively stable compared to last year's transaction price, with a decrease of over 10% compared to the same period in 2023.
Tuoqu Zhuli has a market price of 780. In the second quarter, the market rose by more than 3% in April, and continued to decline in May. The market amplitude narrowed in June.
Levamisole hydrochloride, the market is stable, slightly lower than last week's market.
Aminopyrine hydrochloride has a stable market with a trading price of around 325 yuan. In the second quarter, the trading market price range was 329-315 yuan in April, followed by a strong trend in May and a decline in June.
Metronidazole has a market price of around 80, which is basically the same as last week's price. The average prices for the same period from 2025 to 2023 are 79, 78, and 85, respectively.
Dimetronidazole prices remained relatively stable compared to last week, reaching a peak in April of the second quarter and gradually declining in May. The average prices from April to June last year were 92, 95, and 98, respectively.
Praziquantel, with strong performance, market price of 335.
Cyclopropylhydrazine, with a stable market price of 115.
The analysis of this market data only represents personal opinions and is a comprehensive price of bulk products for reference only. It is not used as a real-time quotation basis or investment basis.
The prices of antipyretic and analgesic products have fluctuated and adjusted, with Flunixin and Carbapentin Calcium rising.
Flunixin methyl formamide is operating strongly, with a market price range of 375-395. In the second quarter, the market remained stable with a slight decline from April to May, but rebounded in June and remained stable in July.
An Naijin, market price 85.
Acetaminophen, with weak performance, entered the fast lane with a decrease in transaction prices in June of the second quarter.
Aspirin, with strong performance, market price of 22800/ton.
Kabapilin calcium is operating strongly, with a market price of around 35, and an increase of over 10% in June.
Aminopyrine, with a market price of 125, has increased compared to last week's market, but remained relatively stable compared to the same period last year. The market remained stable at around 100 in the first quarter.
Aminophylline, strong operation, market price of 125.
Taurine, running weakly, entered July with a significant decline in the trading market.
According to relevant information, in June, Shandong Xinhua Pharmaceutical Co., Ltd. passed the veterinary drug GMP inspection for non sterile raw materials such as metamaterial, aminopyrine, and antipyrine.
The overall downward trend of animal medicine excipient products.
Acetyl methyl quinoline, market fluctuation adjustment.
Sodium camphor sulfonate has seen an increase in supply and a significant decline in trading prices.
Pumin, market price 155, the decline narrowed in late May, and the market trend stabilized in June.
Sodium salicylate has seen a slight rebound in the market, with ample room for negotiation in bulk trading prices.
Citric acid, with a declining market price of 3800/ton.
Sodium citrate, with a declining market price of 3750/ton.
Sodium carbonate, operating weakly, with a market price of 1400/ton.
Sodium bicarbonate, operating weakly, with a market price of 1420/ton.
Glucose, stable market, trading price 3950-6000/ton.
Jiayi Powder has a stable market with a trading price of 2600-3100 tons.
Soluble starch, market price 13100/ton.
Beta cyclodextrin, market price 18000/ton.
The overall downward trend of plant raw materials and traditional Chinese medicine products.
Shuanghuanglian extract, 49-110.
Astragalus polysaccharide extract, 50-120.
Scutellaria baicalensis extract, 100-150.
Licorice extract, 70-100.
Honeysuckle extract, 49-100.
Honeysuckle, 40-100.
Danshen, 8-10
Huanglian, 240-279.
Huangqi, 8-13.
Huangqin, 12-20.
Yanhusuo, 55-70.
Chenpi, 10-13.
Hawthorn, 6-9.
Licorice, 8-14.
Dried ginger, 16-25.
Red flower, 49-79.
Banlangen, 19-29.
The overall market for vitamin products remains stable.
VA, operating at a slightly weak level, with a mixing ratio of 92 and a water solubility of 100.
VB1, stable with a slight increase, nitric acid 239, hydrochloric acid 295.
VB2, 98% purity priced at 288, 80% purity priced at 78.
VB6, with strong performance, has a market price of 110.
VB12, 1%, market price 94, stable market condition.
VC, market quotation: feed grade 19-23, pharmaceutical grade 35.
VD3, market rebound, market price for mixing material 120, water solubility 135.
VE, slightly weak operation, mixing material 80, water solubility 99.
VK3, market price 100.
Calcium pantothenate, market price has fallen, with a current market price of 79.
Nicotinamide, market price 43.
Biotin 2%, market price 37.
Folic acid, with a stable market situation, has a market price of 330.
The above is the market data for veterinary drug ingredients released by the Asia-Pacific Easy and Data Analysis Research Institute. Please leave a message for correction. To learn more, please join as a member to stay informed about real-time market dynamics.
Asia-Pacific Easy and Data Analysis Research Institute is an organization dedicated to data analysis and research in the veterinary drug active pharmaceutical ingredient (API) industry. It primarily provides services such as market analysis, industry trend research, and data report publishing for veterinary drug APIs. With nearly two decades of data, the institute organizes, analyzes, and studies data on prices, supply and demand, and production capacity in the veterinary drug API market. It provides decision-making references for veterinary drug companies, farmers, investors, and others, helping them understand market dynamics, grasp industry trends, and optimize business strategies. The reports and data it publishes hold high authority and influence within the veterinary drug industry, serving as one of the important sources of information for industry participants to understand the market.
10个月宝宝每天需要喝多少奶粉？
